This online, on-demand virtual symposium brings together renowned experts HR+/HER2- breast cancer. In this educational program, these experts review recent key findings and discuss their potential implications for community oncologists. The program features dynamic discussions, practical insights, and the latest data from pivotal clinical trials. The format is designed to provide actionable, evidence-based guidance specifically tailored to help community-based oncology professionals seamlessly integrate these advances into their everyday practice to optimize patient care. This educational activity is an archive of the live presentation held on September 23, 2026.
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
MOC types
FDA REMS
Qualifies for MIPS
Target Specialties
No specific specialties targeted.
Address:
- 259 Prospect Plains Rd, Bldg H
Pricing
100% of listed courses are free
265 of 265 courses listed here are free.
Collected from the provider’s public pages · source
Specialties served/covered
- Allergy & Clinical Immunology
- Anatomic & Clinical Pathology
- Cardiovascular Disease
- Communication & Shared Decision-Making
- Dermatology
- Endocrinology, Diabetes & Metabolism
- Evidence-Based Medicine & Research
- Family Medicine
- Gastroenterology
- Gastrointestinal Surgery
- General & Adult Psychiatry
- General Internal Medicine
- General Pediatrics
- Geriatric Medicine
- Gynecologic Oncology
- Head & Neck Surgery
- Health Equity & Inclusion
- Hematology
- Infectious Disease
- Medical Oncology
- Metabolic & Bariatric Surgery
- Mood & Anxiety Disorders
- Nephrology
- Neurology
- Neuromuscular Medicine
- Neuroradiology
- Neurosurgery
- Nuclear Medicine
- Ophthalmology
- Pediatric Hematology-Oncology
- Psychotic Disorders
- Pulmonary Disease
- Radiation Oncology
- Rheumatology
- Surgical Oncology
- Urological Oncology
- Cardio-Vascular
- Cross-Specialty
- ENT & Head Neck
- GI & Liver
- Infectious Disease
- Internal Medicine
- Medical Subspecialties
- Neurology
- Oncology & Hematology
- Pathology & Lab
- Pediatrics
- Primary care
- Psychiatry
- Radiology
- Surgery
- Urology
- No reviews yet. Be the first to share yours.
Pricing
Free
Reported to ACCME by the provider
- On-demand / recorded video
- Credit · Up to 1 credit
- Commercial Support
-
ReleasedOct 2, 2026
-
Last day to claim creditNov 6, 2026 4 weeks left
-
Physicians’ Education Resource Community Oncology Connections(TM): How Can We Optimize the Use of Oral SERDs in the Community Oncology Setting? Best Practices for HR+/HER2- Breast Cancer | Wisconsin Association of Hematology and Oncology
-
Physicians’ Education Resource Community Oncology Connections(TM): How Can We Optimize the Use of Oral SERDs in the Community Oncology Setting? Best Practices for HR+/HER2- Breast Cancer | Empire State Hematology & Oncology Society
-
Physicians’ Education Resource Community Oncology Connections(TM): Monotherapies vs Combinations – Navigating Oral SERDs and Targeted Combination Strategies in HR+/HER2- Metastatic Breast Cancer | Nevada Oncology Society
-
Med Learning Group The Emerging Role of Oral SERDs in Community Care for Frontline HR+/HER2- Metastatic Breast Cancer
-
Answers in CME Inc. (AiCME) Integrating ESR1m Testing and Novel Oral SERDS Into Multidisciplinary Workflows: Regional Guidance for HR+, HER2- Advanced Breast Cancer
-
Research to Practice Patterns of Care: Exploring How Community Oncologists Manage HR-Positive, HER2-Positive mBC | 2026 (Webinar Proceedings)
